Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zylox-Tonbridge Medical Technology Co Ltd
Long-Term Debt
Zylox-Tonbridge Medical Technology Co Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Long-Term Debt
¥7.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Long-Term Debt
¥11.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Long-Term Debt
¥7.3m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Long-Term Debt
¥225.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Long-Term Debt
¥2.2B
|
CAGR 3-Years
387%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Long-Term Debt
¥84m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.
See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Long-Term Debt?
Long-Term Debt
7.5m
CNY
Based on the financial report for Dec 31, 2025, Zylox-Tonbridge Medical Technology Co Ltd's Long-Term Debt amounts to 7.5m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-23%
Over the last year, the Long-Term Debt growth was 0%.
